Search

Your search keyword '"Pantuck, Allan J."' showing total 142 results

Search Constraints

Start Over You searched for: Author "Pantuck, Allan J." Remove constraint Author: "Pantuck, Allan J." Publisher wolters kluwer uk Remove constraint Publisher: wolters kluwer uk
142 results on '"Pantuck, Allan J."'

Search Results

1. Prognostic Impact of Preoperative Neutrophil-to-Lymphocyte Ratio in Localized Nonclear Cell Renal Cell Carcinoma.

2. Prognostic Value of Microvascular Invasion in Predicting the Cancer Specific Survival and Risk of Metastatic Disease in Renal Cell Carcinoma: A Multicenter Investigation.

3. The Chromophobe Tumor Grading System is the Preferred Grading Scheme for Chromophobe Renal Cell Carcinoma.

4. Integrated Safety Data From 4 Randomized, Double-Blind, Controlled Trials of Autologous Cellular Immunotherapy With Sipuleucel-T in Patients With Prostate Cancer.

6. Pathological, Immunohistochemical and Cytogenetic Features of Papillary Renal Cell Carcinoma With Clear Cell Features.

7. Development and External Validation of a Nomogram Predicting Disease Specific Survival After Nephrectomy for Papillary Renal Cell Carcinoma.

8. Absent CD44v6 Expression is an Independent Predictor of Poor Urothelial Bladder Cancer Outcome.

9. Fuhrman Grade Provides Higher Prognostic Accuracy Than Nucleolar Grade for Papillary Renal Cell Carcinoma.

10. Conditional Survival Predictions After Nephrectomy for Renal Cell Carcinoma.

11. Cytoreductive Nephrectomy for Kidney Cancer With Sarcomatoid Histology—Is Up-Front Resection Indicated and, if Not, is it Avoidable?

12. CA9 Gene: Single Nucleotide Polymorphism Predicts Metastatic Renal Cell Carcinoma Prognosis.

13. Presence of Tumor Necrosis is Not a Significant Predictor of Survival in Clear Cell Renal Cell Carcinoma: Higher Prognostic Accuracy of Extent Based Rather Than Presence/Absence Classification.

14. Intraoperative Thrombus Embolization During Nephrectomy and Tumor Thrombectomy: Critical Analysis of the University of California-Los Angeles Experience.

15. Tumor Size Does Not Predict Risk of Metastatic Disease or Prognosis of Small Renal Cell Carcinomas.

16. Proteomic Identification of Interleukin-2 Therapy Response in Metastatic Renal Cell Cancer.

17. The Chemokine Receptor CXCR3 is an Independent Prognostic Factor in Patients With Localized Clear Cell Renal Cell Carcinoma.

18. A Novel Resectoscope for Transurethral Resection of Bladder Tumors and the Prostate.

19. The Prevalence of Malignancy in Satellite Renal Lesions and its Surgical Implication During Nephron Sparing Surgery.

20. Prognostic Factors for Renal Cell Carcinoma With Tumor Thrombus Extension.

21. Prognostic Impact of Tumor Size on pT2 Renal Cell Carcinoma: An International Multicenter Experience.

22. p53 IS AN INDEPENDENT PREDICTOR OF TUMOR RECURRENCE AND PROGRESSION AFTER NEPHRECTOMY IN PATIENTS WITH LOCALIZED RENAL CELL CARCINOMA.

31. NEPHRON-SPARING SURGERY VS. RADICAL NEPHRECTOMY IN PATIENTS WITH RENAL CELL CARCINOMA >7 CM. WITH NO EVIDENCE OF NODAL OR DISTANT METASTATSIS.

32. POSITIVE SURGICAL MARGINS APPEAR TO HAVE NEGLIGIBLE IMPACT ON THE SURVIVAL OF RENAL CELL CARCINOMAS TREATED BY NEPHRON SPARING SURGERY.

33. PREDICTIVE FACTORS FOR LOCAL RECURRENCE AFTER NEPHRON SPARING SURGERY IN RENAL CELL CARCINOMA.

36. 996: Prognostic Significance of T3A Renal Cell Carcinoma with Adrenal Gland Involvement: An International Multicenter Experience.

41. 1337: Endothelial Expression of Vascular Endothelial Growth Factor Receptor 3 (VEGFR-3), but not VEGFR-1 or VEGFR-2, Predicts Survival in Clear Cell Renal Cell Carcinoma (RCC).

50. 304 DC-AD-GMCAIX BASED VACCINE THERAPY IS SAFE AND EFFECTIVE IN IMMUNOCOMPETENT MURINE KIDNEY CANCER TUMOR MODELS.

Catalog

Books, media, physical & digital resources